BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 36808033)

  • 1. Repurposing of phyto-ligand molecules from the honey bee products for Alzheimer's disease as novel inhibitors of BACE-1: small molecule bioinformatics strategies as amyloid-based therapy.
    Nisa N; Rasmita B; Arati C; Uditraj C; Siddhartha R; Dinata R; Bhanushree B; Bidanchi RM; Manikandan B; Laskar SA; Abinash G; Pori B; Roy VK; Gurusubramanian G
    Environ Sci Pollut Res Int; 2023 Apr; 30(17):51143-51169. PubMed ID: 36808033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multitargeted Molecular Docking and Dynamic Simulation Studies of Bioactive Compounds from
    Mirza FJ; Zahid S; Amber S; Sumera ; Jabeen H; Asim N; Ali Shah SA
    Molecules; 2022 Oct; 27(21):. PubMed ID: 36364071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concatenation of molecular docking and molecular simulation of BACE-1, γ-secretase targeted ligands: in pursuit of Alzheimer's treatment.
    Jabir NR; Rehman MT; Alsolami K; Shakil S; Zughaibi TA; Alserihi RF; Khan MS; AlAjmi MF; Tabrez S
    Ann Med; 2021 Dec; 53(1):2332-2344. PubMed ID: 34889159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of new BACE1 inhibitors for treating Alzheimer's disease.
    Kushwaha P; Singh V; Somvanshi P; Bhardwaj T; Barreto GE; Ashraf GM; Mishra BN; Chundawat RS; Haque S
    J Mol Model; 2021 Jan; 27(2):58. PubMed ID: 33517514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computational modelling of potent β-secretase (BACE1) inhibitors towards Alzheimer's disease treatment.
    Ugbaja SC; Sanusi ZK; Appiah-Kubi P; Lawal MM; Kumalo HM
    Biophys Chem; 2021 Mar; 270():106536. PubMed ID: 33387910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In Silico Inhibition of BACE-1 by Selective Phytochemicals as Novel Potential Inhibitors: Molecular Docking and DFT Studies.
    Arif N; Subhani A; Hussain W; Rasool N
    Curr Drug Discov Technol; 2020; 17(3):397-411. PubMed ID: 30767744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repurposing immune boosting and anti-viral efficacy of
    Dinata R; Nisa N; Arati C; Rasmita B; Uditraj C; Siddhartha R; Bhanushree B; Saeed-Ahmed L; Manikandan B; Bidanchi RM; Abinash G; Pori B; Khushboo M; Roy VK; Gurusubramanian G
    J Biomol Struct Dyn; 2024; 42(1):43-81. PubMed ID: 37021347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alzheimer's Disease and β-secretase Inhibition: An Update with a Focus on Computer-aided Inhibitor Design.
    Ugbaja SC; Lawal IA; Kumalo HM; Lawal MM
    Curr Drug Targets; 2022; 23(3):266-285. PubMed ID: 34370634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fetzima (levomilnacipran), a drug for major depressive disorder as a dual inhibitor for human serotonin transporters and beta-site amyloid precursor protein cleaving enzyme-1.
    Rizvi SM; Shaikh S; Khan M; Biswas D; Hameed N; Shakil S
    CNS Neurol Disord Drug Targets; 2014; 13(8):1427-31. PubMed ID: 25345508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of potential lead compounds against BACE1 through in-silico screening of phytochemicals of Medhya rasayana plants for Alzheimer's disease management.
    Nadh AG; Revikumar A; Sudhakaran PR; Nair AS
    Comput Biol Med; 2022 Jun; 145():105422. PubMed ID: 35354103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In silico repurposing of antipsychotic drugs for Alzheimer's disease.
    Kumar S; Chowdhury S; Kumar S
    BMC Neurosci; 2017 Oct; 18(1):76. PubMed ID: 29078760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening and Elucidation of Selected Natural Compounds for Anti- Alzheimer's Potential Targeting BACE-1 Enzyme: A Case Computational Study.
    Ahmad SS; Akhtar S; Danish Rizvi SM; Kamal MA; Sayeed U; Khan MKA; Siddiqui MH; Arif JM
    Curr Comput Aided Drug Des; 2017 Nov; 13(4):311-318. PubMed ID: 28413992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BACE1 molecular docking and anti-Alzheimer's disease activities of ginsenosides.
    Choi RJ; Roy A; Jung HJ; Ali MY; Min BS; Park CH; Yokozawa T; Fan TP; Choi JS; Jung HA
    J Ethnopharmacol; 2016 Aug; 190():219-30. PubMed ID: 27275774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring the Molecular Structural Requirements of Flavonoids as Beta- Secretase-1 Inhibitors Using Molecular Modeling Studies.
    More UA; Noolvi MN; Kumar D; Tripathi A
    Curr Drug Discov Technol; 2023; 20(3):e290323215095. PubMed ID: 36999415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biaryl scaffold-focused virtual screening for anti-aggregatory and neuroprotective effects in Alzheimer's disease.
    Khalid S; Zahid MA; Ali H; Kim YS; Khan S
    BMC Neurosci; 2018 Nov; 19(1):74. PubMed ID: 30424732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repurposing food molecules as a potential BACE1 inhibitor for Alzheimer's disease.
    Mukerjee N; Das A; Jawarkar RD; Maitra S; Das P; Castrosanto MA; Paul S; Samad A; Zaki MEA; Al-Hussain SA; Masand VH; Hasan MM; Bukhari SNA; Perveen A; Alghamdi BS; Alexiou A; Kamal MA; Dey A; Malik S; Bakal RL; Abuzenadah AM; Ghosh A; Md Ashraf G
    Front Aging Neurosci; 2022; 14():878276. PubMed ID: 36072483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Virtual screening, pharmacokinetics, molecular dynamics and binding free energy analysis for small natural molecules against cyclin-dependent kinase 5 for Alzheimer's disease.
    Shukla R; Singh TR
    J Biomol Struct Dyn; 2020 Jan; 38(1):248-262. PubMed ID: 30688165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The potential of natural product vs neurodegenerative disorders: In silico study of artoflavanocoumarin as BACE-1 inhibitor.
    Razzaghi-Asl N; Karimi A; Ebadi A
    Comput Biol Chem; 2018 Dec; 77():307-317. PubMed ID: 30445338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular docking based virtual screening of natural compounds as potential BACE1 inhibitors: 3D QSAR pharmacophore mapping and molecular dynamics analysis.
    Kumar A; Roy S; Tripathi S; Sharma A
    J Biomol Struct Dyn; 2016; 34(2):239-49. PubMed ID: 25707809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of intermolecular interactions and stability of verubecestat in the active site of BACE1: Development of first model from QM/MM-based charge density and MD analysis.
    Saravanan K; Sivanandam M; Hunday G; Mathiyalagan L; Kumaradhas P
    J Biomol Struct Dyn; 2019 Jun; 37(9):2339-2354. PubMed ID: 30044206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.